Media Kit

The Recursion Media Kit provides key materials for journalists to use when covering the Company. Please contact our communications team if you need more information or to schedule an interview.

media@recursion.com

Approved company description

Recursion (NASDAQ: RXRX) is a leading, clinical-stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS), a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale—up to millions of wet lab experiments weekly—and massive computational scale—owning and operating one of the most powerful supercomputers in the world—Recursion is uniting technology, biology, chemistry and patient-centric data to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of
BioHive, the Utah life sciences industry collective. Recursion also has other primary offices in Toronto, Montreal, the San Francisco Bay Area, New York, the Oxford area, and London.

Meet our Leaders

Chris Gibson

Co-Founder and CEO
View Bio

Erica Fox

Chief People and Impact Officer
View Bio

David Hallett

Chief Scientific Officer
View Bio

Nathan Hatfield

Chief Legal Officer & General Counsel
View Bio

Najat Khan

Chief R&D Officer and Chief Commercial Officer
View Bio

Matt Kinn

Chief Business Officer
View Bio

Ben Mabey

Chief Technology Officer
View Bio

David Mauro

Chief Medical Officer
View Bio

Lina Nilsson

SVP Head of Platform
View Bio

Kristen Rushton

Chief Operations Officer
View Bio

Ben Taylor

Chief Financial Officer & President Recursion UK
View Bio

Press Contact